"In 1951, Redmond made history as the first city in Oregon to form a public hospital district. Central Oregon District Hospital was built in 1952 on 20 acres north of town. The public supported the hospital with tax dollars and community members were elected to serve on the Board of Directors up until the time of the merger between the Bend and Redmond hospitals. As part of its continued commitment to the Redmond community, St. Charles Health System invested in the Redmond facility through a $30 million addition that opened in 2006."

During the past decade, Saint Charles Health System-Redmond conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 14 clinical trials were completed, i.e. on average, 14.1% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 14 clinical trials were completed. i.e. 26.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Charles Health System-Redmond" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "NRG Oncology" with 15 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Charles Health System-Redmond" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Saint Charles Health System-Redmond" are "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Metastatic Malignant Neoplasm in the Brain" (5 trials), "Clinical Stage IV Cutaneous Melanoma AJCC v8" (4 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Saint Charles Health System-Redmond" in a lesser frequency.

Most popular intervention types in "Saint Charles Health System-Redmond" are "Drug" (85 trials), "Biological" (51 trials), "Other" (48 trials), "Procedure" (34 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Biospecimen Collection" (23 trials), "Computed Tomography" (22 trials), "Nivolumab" (20 trials) and "Questionnaire Administration" (17 trials). Other intervention names were less common.

The vast majority of trials in "Saint Charles Health System-Redmond" are 95 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Charles Health System-Redmond". undefined are not yet recruiting, 49 are recruiting, 47 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Saint Charles Health System-Redmond, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Charles Health System-Redmond, 3 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".